Our Viewpoints

November 2021

Building the Field Force of the Future

Today’s oncology field force in the pharmaceutical industry—the people  responsible for connecting patient care teams with therapeutic innovations—looks much different than it has in recent years.

September 2021

Why Leaders Should “Bless the Mess”

I am proud of how Takeda – like so many companies around the world – has adapted and embraced new ways of working over the past year-and-a-half. As Head of Global Oncology Patient Value, Policy and Access (PVPA) at Takeda, I also miss in-person interactions with my team and colleagues and look forward to returning to the workplace soon

August 2021

The Importance of Time Off from Work

I’ve always been a firm believer in the power of personal time off. I recently went on vacation and returned feeling completely revitalized. I find that this personal time away gives me a fresh perspective, renewed energy and space to think more creatively.

July 2021

Real-world evidence in the multiple myeloma treatment landscape

In our time at Takeda Oncology, we’ve had the opportunity to observe how real-world evidence (RWE) obtained outside of randomized controlled trials (RCTs) has been playing an increasingly important role in understanding treatment options for patients, especially in the field of multiple myeloma research.

June 2021

Advocating for Patients as Research Advances in Lung Cancer

Within the past 10 years, the diagnosis and treatment of lung cancer has advanced rapidly – making the outlook for many individuals diagnosed with lung cancer today nearly unrecognizable compared to what those from previous decades had encountered.

Harnessing the Innate Immune System to Outsmart Cancer

One of the most exciting things about working in oncology today is the rapid pace of progress. The speed of scientific innovation, the speed that is possible through innovative trial designs and the speed with which regulators engage to help us advance investigational therapeutics to realize their potential for cancer patients is nothing short of astounding. 

May 2021

Explore More

Leadership Team

Our Executive Leadership team is designed to drive customer proximity, nimbleness, agility and accountability 

R&D Approach

Decades of leadership in Oncology with a diverse and robust pipeline

Oncology Pipeline

Discovering and developing innovative therapies to deliver potentially transformative treatments